Welcome to Neuro-Oncology Pediatrics
Neuro-Oncology Pediatrics · 2025
DOI: 10.1093/neuped/wuaf003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Pediatrics, 2025. Verfasst von Sabine Mueller und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It is with great excitement and deep purpose that we launch Neuro-Oncology Pediatrics, a new open-access journal dedicated to advancing the science and care of children and adolescents and young adults (AYAs) with central nervous system tumors. As the editorial leadership team, we—alongside our esteemed Associate Editors and Editorial Board—invite you to join us in building a platform that reflects the vibrancy, innovation, and collaboration that define the pediatric neuro-oncology community. Our mission is to serve as the leading global forum for pioneering research that transforms care and outcomes for children and AYAs with brain and spinal tumors. The decision to establish Neuro-Oncology Pediatrics reflects a pivotal moment in our field. This journal is proudly supported by the Asian Society for Neuro-Oncology (ASNO), the European Association of Neuro-Oncology (EANO), and the Society for Neuro-Oncology (SNO). We are grateful for their partnership and shared vision to promote excellence across the neuro-oncology spectrum. We also express our sincere appreciation to Dr Susan Chang (Neuro-Oncology), Dr Martin Taphoorn (Neuro-Oncology Practice), and Dr Gelareh Zadeh (Neuro-Oncology Advances) for their enthusiastic development and support of this new journal. Our collaboration with these sister journals will ensure alignment of standards, cross-disciplinary engagement, and scientific rigor. Over the past decade, we have witnessed remarkable progress in the biology, diagnosis, and treatment of pediatric brain tumors—progress driven by rigorous basic and translational science, collaborative clinical trials, and a steadfast commitment to improving outcomes. The recent FDA approvals of therapies specifically for pediatric brain tumors underscore this momentum and highlight the field’s growing influence in reshaping how we care for children and young adults with brain tumors. At the same time, the increasing knowledge and complexity of pediatric neuro-oncology demands a journal tailored to its unique challenges and opportunities. Neuro-Oncology Pediatrics is designed to be that home: a place where discoveries in tumor biology, diagnostics, clinical trial outcomes, survivorship and late effects, and health equity can be explored with the depth and focus they deserve. We also value contributions that incorporate the voices of patients and their families, recognizing their critical role in shaping meaningful research and care. Our scope spans the full translational continuum—from preclinical models and molecular insights to clinical trials and survivorship. We are particularly committed to amplifying research that improves global outcomes, recognizing that pediatric neuro-oncology is a global discipline with disparities in access, resources, and infrastructure that must be addressed collectively. We strive to serve the global pediatric and AYA community. We have assembled an internationally recognized Editorial Board that reflects the diverse expertise needed to advance the field. Our peer-review process will be rigorous and fair, modeled after the high standards set by the Neuro-Oncology family of journals. Furthermore, we aim to nurture early-career scientists and clinicians through dedicated opportunities for publication, recognition, and collaboration. As with any new endeavor, the success of Neuro-Oncology Pediatrics will rely on the strength and commitment of our global community. We invite you to submit your most impactful work and help shape a journal created by and for experts dedicated to pediatric and AYA neuro-oncology. Together, we can create a transformative and meaningful resource—one that not only advances science but also serves the ultimate goal of improving the lives and driving equity of children and young adults with brain and spinal cord tumors across the world. We thank you for your support and look forward to growing this journal with you. Sabine Mueller, MD, PhD, MAS Editor-in-Chief Marta M. Alonso, PhD Executive Editor, EANO Yoshiki Arakawa, MD, PhD Executive Editor, ASNO Pratiti Bandopadhayay, MBBS, PhD Executive Editor, SNO None declared. PB has served on paid advisory boards for Day One Biopharmaceuticals and QED Therapeutics. She has received grant funding from Novartis Institute of Biomedical Research. SM has served for a paid advisory board for DayOne Biopharmaceuticals. All authors were involved in drafting, finalizing and approving the editorial.
Zitieren
APA
Mueller, S., Alonso, M. M., Arakawa, Y., & Bandopadhayay, P. (2025). Welcome to Neuro-Oncology Pediatrics. Neuro-Oncology Pediatrics. https://doi.org/10.1093/neuped/wuaf003
Vancouver
Mueller S, Alonso MM, Arakawa Y, Bandopadhayay P. Welcome to Neuro-Oncology Pediatrics. Neuro-Oncology Pediatrics. 2025. doi:10.1093/neuped/wuaf003
BibTeX
@article{Mueller2025,
author = {Mueller, Sabine and Alonso, Marta M and Arakawa, Yoshiki and Bandopadhayay, Pratiti},
title = {Welcome to Neuro-Oncology Pediatrics},
journal = {Neuro-Oncology Pediatrics},
year = {2025},
doi = {10.1093/neuped/wuaf003}
}
EUVIMED